Badrilla

Badrilla公司概況

Badrilla公司創(chuàng)立于2003年，是一家為從事分子心血管研究的科研工作者提供上等產(chǎn)品的生命科學公司，客戶來自包括制藥、生物技術(shù)企業(yè)以及科研單位等。Badrilla結(jié)合精細有機化學、蛋白化學等精湛的專長以及翻譯后修飾蛋白的專業(yè)知識協(xié)助研究者開展心血管領(lǐng)域做***的研究，比如研究協(xié)調(diào)心臟興奮收縮的相關(guān)蛋白，心律失常和病理性肥大，以及適應(yīng)**反應(yīng)導致心臟衰竭等課題。過去十幾年里，Badrilla的產(chǎn)品成功的支持血管生化領(lǐng)域的重大發(fā)現(xiàn)，公司也獲得了廣泛贊譽，這份榮譽來自世界范圍內(nèi)知名科學家使用本公司產(chǎn)品而發(fā)表的數(shù)據(jù)。與客戶攜手并進，Badrilla將一如既往的**產(chǎn)品和服務(wù)，并擴展和加強在心血管領(lǐng)域領(lǐng)頭羊的地位，努力和廣大科研工作者實現(xiàn)互惠互利。 

使命

Badrilla致力于開發(fā)高品質(zhì)試劑，使科研工作者、研究贊助商能在心血管科學領(lǐng)域做出新的突破，為相關(guān)病患帶來福音。 

Badrilla主要提供心血管靶標單克隆及多克隆抗體(心血管蛋白及磷酸化蛋白靶標)、標簽抗體、硝基酪氨酸抗體、SUMO化蛋白捕獲與檢測試劑盒、抑制劑等。 

Company Profile

Badrilla Ltd, founded in 2003, is an established life science company providing high quality products for the molecular cardiovascular researcher located within major pharmaceutical, biotech, and academic establishments worldwide. Badrilla assists researchers in combining its expertise of meticulous organic and protein chemistry with its knowledge of the post-translational modification of the proteins that coordinate cardiac excitation-contraction coupling, cardiac arrhythmia and hypertrophy, and the maladaptive response leading to heart failure, in order to produce research tools of the highest integrity and broadest application.Over the past ten years Badrilla products have helped to underpin key discoveries in cardiac biochemistry and the Company has garnered a wealth of published data from respected scientists worldwide.  Working in concert with its Clients, Badrilla continues to develop new products and services which will both expand and strengthen its focussed position to mutual benefit.